The increase in international tourism has created demand for vaccination to protect against travel-associated illness. The decision to vaccinate travellers involves risk-benefit assessment. Most currently used travel vaccines include the meningococcal vaccine, yellow fever vaccine, typhoid vaccine, and Japanese encephalitis vaccine.

This review addresses the limitations posed by the meningococcal polysaccharide vaccine, the different quadrivalent meningococcal conjugate vaccines available, the current recommendations in children and adults and the development of new meningococcal B vaccines.

This review also addresses the current recommendations for yellow fever vaccines, new typhoid conjugate vaccines, changing epidemiology of Japanese encephalitis (JE), and new recommendations for the JE vaccines